Why is ANG Lifesciences falling/rising?

As of 23-Jun, ANG Lifesciences India Ltd is experiencing a decline in its stock price, currently at 28.10, reflecting a decrease of 0.46 or 1.61%. The stock has underperformed its sector today by 1.6% and has been on a consecutive downward trend for the last six days, accumulating a total loss of 6.33% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. The company has reported operating losses and has shown weak long-term fundamental strength, evidenced by a high Debt to EBITDA ratio of 5.83 times and negative returns on equity. Furthermore, the company has declared negative results for the last 12 consecutive quarters, with a significant drop in profit before tax and a low return on capital employed, contributing to its recent stock price decline.
In the broader market context, ANG Lifesciences has consistently underperformed against the benchmark, with a year-to-date return of -37.12% compared to the Sensex's gain of 4.81%. Over the past three years, the stock has generated returns of -82.77%, while the benchmark has risen by 56.69%. This stark contrast highlights the company's ongoing struggles, particularly in a market that has shown resilience. The high percentage of pledged promoter shares, at 44.88%, adds further pressure on the stock in a declining market, indicating a lack of confidence among investors and exacerbating the stock's downward trajectory.